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Abstract
Background:  The epidemic form of Bovine Spongiform Encephalopathy (BSE) is generally
considered to have been caused by a single prion strain but at least two strain variants of cattle
prion disorders have recently been recognized. An additional neurodegenerative condition,
idiopathic brainstem neuronal chromatolysis and hippocampal sclerosis (IBNC), a rare neurological
disease of adult cattle, was also recognised in a sub-set of cattle submitted under the BSE Orders
in which lesions of BSE were absent. Between the years of 1988 and 1991 IBNC occurred in
Scotland with an incidence of 7 cases per 100,000 beef suckler cows over the age of 6 years.
Results: When the brains of 15 IBNC cases were each tested by immunohistochemistry, all
showed abnormal labelling for prion protein (PrP). Immunohistological labelling for PrP was also
present in the retina of a single case available for examination. The pattern of PrP labelling in brain
is distinct from that seen in other ruminant prion diseases and is absent from brains with other
inflammatory conditions and from normal control brains. Brains of IBNC cattle do not reveal
abnormal PrP isoforms when tested by the commercial BioRad or Idexx test kits and do not reveal
PrPres when tested by Western blotting using stringent proteinase digestion methods. However,
some weakly protease resistant isoforms of PrP may be detected when tissues are examined using
mild proteinase digestion techniques.
Conclusion: The study shows that a distinctive neurological disorder of cattle, which has some
clinical similarities to BSE, is associated with abnormal PrP labelling in brain but the pathology and
biochemistry of IBNC are distinct from BSE. The study is important either because it raises the
possibility of a significant increase in the scope of prion disease or because it demonstrates that
widespread and consistent PrP alterations may not be confined to prion diseases. Further studies,
including transmission experiments, are needed to establish whether IBNC is a condition in which
prion protein is abnormally regulated or it is yet a further example of an infectious cattle prion
disease.
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Background
The transmissible spongiform encephalopathies, or prion
diseases, are fatal neurodegenerative diseases character-
ized by the accumulation of a post-translationally modi-
fied variant of the host coded Prion protein (PrP). Until
recently, only one form of naturally occurring cattle prion
disease was recognized. However, extensive testing of
sheep and cattle destined for the human food chain have
recently revealed the presence of hitherto unsuspected
variant forms of transmissible spongiform encephalopa-
thy of cattle [1,2] and also of sheep [3].
Idiopathic brainstem neuronal chromatolysis and hip-
pocampal sclerosis (IBNC) is a disorder of adult cattle
which has some clinical similarity to bovine spongiform
encephalopathy [4,5]. It was initially recognised from his-
tological examination of cattle brains submitted as part of
the UK statutory reporting of BSE suspects [6]. The disease
is rare. In the period from 1988 to1991 it occurred at a
rate of 7 cases per 100,000 beef suckler cows over the age
of 6 years and 2.68 cases per 100,000 dairy cows of the
same age [5]. The mean age of onset is 9 years with a range
of 4 – 16 years. Most cases have been reported in Scotland
and cases have also been diagnosed in England and Wales,
but not from outside the UK. Most cases of IBNC occur
singly on farms, but two farms have been identified which
have experienced two cases each (MJ personal observa-
tions). The proportion of IBNC cases detected through the
early 1990s was relatively consistent at 12–14% per year
of the BSE negative case subset. During the peak of the BSE
epidemic, 27 IBNC cases were recognized in Scotland in
one year (MJ personal observations). IBNC cases contin-
ued to be found in recent years but there has been a fall in
absolute numbers within the BSE negative subset. At least
some IBNC cases have distinguishing clinical features
from BSE [7] and the fall in histological diagnosis of IBNC
cases may be a reflection of an increasingly critical
appraisal of clinical signs when suspect BSE cases are
examined in the field.
The pathological lesions of IBNC are distinctive and char-
acterised by four types of histological change [4]. Neuro-
nal degeneration and axonal degeneration involving
brainstem and cranial nerve nuclei and radices of cranial
nerves, accompanied by a non-suppurative inflammation
proportionate to the degenerative changes, are invariably
present. In approximately half the cases examined there is
a spongiform change involving grey matter of medial and
lateral geniculate nuclei, thalamus, hippocampus, stria-
tum and cerebral cortex, together with hippocampal
degeneration and sclerosis involving extensive loss of neu-
rons [4]. The spongiform changes of IBNC involve neuro-
anatomical areas different from those vacuolated in BSE
affected brains.
Testing for a number of different metabolic disorders,
including vitamin B, vitamin E and selenium deficiency,
the presence of antigens to Louping ill virus, Aujeszky's
disease virus, Borna virus and Bovine Virus Diarrhoea
virus failed to show any significant abnormalities (MJ per-
sonal observations). Immunohistochemical studies for
PrP were initially performed in the mid-1990s on IBNC
brain tissues using antibodies raised to murine PrP. No
abnormal PrP was detected. Five brains were tested for
scrapie associated fibrils by negative stain electron micro-
scopy and were negative (unpublished data).
PrP immunohistochemistry tests on brains from IBNC
cases performed during the 1990s were done using anti-
bodies of low affinity for bovine PrP and methodologies
that are of lower sensitivity than those currently available.
Recent re-examination of tissues from IBNC cases using
more sensitive labelling methods and antibodies capable
of detecting lower levels of bovine PrP, consistently
revealed PrP labelling in all cases tested. This present
report describes the results of immunohistochemical and
biochemical methods for PrP detection in a series of IBNC
cases.
Methods
Sixteen cases of IBNC were retrieved from the pathology
archives at the VLA Lasswade laboratory. Cases were from
cattle that were between 5 and 15 years of age when killed
between 1993 and 2005. To control for inflammatory and
degenerative changes and time of tissue preservation in
paraffin wax, cases of malignant catarrhal fever, (a herpes
virus infection of cattle), encephalic listeriosis, non-sup-
purative encephalitis, BSE and also, cattle brains with no
significant morphological changes were also retrieved
from the same archive. These latter cases had also been
preserved in paraffin wax since 1992–1994.
Tissues of IBNC cases available for immunohistochemis-
try and, or, biochemistry are listed in table 1. For histology
and immunohistochemical testing, whole brains were
available from 9 IBNC cases: representative samples of
medulla at the obex and cerebellar peduncles, midbrain,
thalamus, striatum, cerebellum hippocampus and cere-
beral cortices were examined. From a single cow, addi-
tional tissues of eye, spleen, adrenal gland and lymph
node were also examined. From the remaining seven cases
only brainstem was available for testing.
The protocol for sampling suspect BSE cases has altered in
the UK over time. Consequently, most IBNC cases from
the early part of the epidemic lacked samples of frozen tis-
sue for biochemical analyses. From the later part of the
epidemic, only medulla was available for biochemical
testing: from 2003 whole brains have been routinely fro-
zen and retained. Samples of frozen brain were availableBMC Veterinary Research 2008, 4:38 http://www.biomedcentral.com/1746-6148/4/38
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from 7 cases on which a diagnosis of IBNC was estab-
lished, based on the histology of medulla. From only one
IBNC brain was half a brain available for biochemistry
and half a brain available for histology. The tissues avail-
able for examination are listed in Table 1.
Histology and immunohistochemistry
All brain sections available were stained with haematoxy-
lin and eosin. Additional blocks of tissue of medulla, mid-
brain and thalamus were impregnated with silver
according to Glees and Marsland's modification of Daven-
port's method for degenerate axons.
For immunohistochemistry, paraffin wax embedded tis-
sues were sectioned at 5 μm, mounted on treated glass
slides (Superfrost Plus; Menzel-Glaser, City, Germany)
and dried overnight at 37°C. Initially, immunohisto-
chemistry carried out in 1993–5 on IBNC cases used the
1B3 antibody, a polyclonal antibody which had been
raised in rabbits to scrapie associated fibrils extracted from
ME7 infected mouse brain. Methods used for epitope
demasking employed only a formic-acid retrieval stage
and did not use autoclaving. Subsequently, in 2007,
immunohistochemistry was carried out as described by
González et al [8]. Briefly, antigen retrieval included
immersion of tissue sections in 98% formic acid for 5 min
and autoclaving in 0.2% citrate buffer for 5 min at 121°C.
After two blocking steps (to quench endogenous peroxi-
dase activity and to remove non-specific tissue antigens),
incubation with the primary antibody was carried out
overnight at 4°C. Subsequent steps were performed using
a commercial immunoperoxidase technique (Vector-elite
ABC kit; Vector Laboratories, Peterborough, UK), after
which sections were immersed in 0.5% copper sulphate,
to enhance immunoperoxidase colour reaction. Finally,
sections were counterstained with Mayer's haematoxylin.
Seven PrP antibodies were used, all of which were first
titrated on BSE infected sheep or cattle brains to deter-
mine the effective dilution range. The antibodies, their
binding or eliciting sequences, and dilutions used are
shown in table 2. All of these antibodies are considerably
more sensitive for detecting bovine PrP than were anti-
bodies used for IBNC labelling in 1993–5. Biotinylated
antibodies were used for secondary enhancement: goat
anti-rat was used to detect antibody R145 and a universal
horse anti-mouse/rabbit was used to detect all other anti-
bodies. For antibody controls, omission of the primary
antibody and anti-isotype antibodies were also employed.
Biochemical methods
TeSeE Western blotting
Sample extraction was carried out according to the manu-
facturer's instructions (Bio-Rad (California, USA) TeSeE
Western Blot) with several modifications. In brief, brain
tissue was ribolysed to give a 20% (w/v) homogenate. The
homogenate was then incubated with DNAase (1/10 dilu-
tion at concentration of 2.5 mg/ml in 0.19 M MgCl2) at
room temperature for 5 minutes. The samples were then
digested with 0.3 units/ml proteinase K (Sigma-Aldrich,
(Dorset, UK)); 0.3 units/ml is an in-house nomenclature
and equivalent to 0.3 μl of Bio-Rad test proteinase K in
terms of activity when compared with the TAME test
(Pierce) or 4 μl/ml proteinase K (Bio-Rad) for 10 minutes,
with digestion stopped by adding 1/25 Pefabloc SC
(Fluka-Sigma-Aldrich, Dorset, UK) (46.7 mM in distilled
H2O). Following precipitation and centrifugation at
15,000 g for 7 minutes, the pellets were incubated at
100°C for 5 minutes in 100 μl Laemmli solution (with
5% (v/v) beta-mercaptoethanol and 2% (w/v) SDS). A
second centrifugation was performed at 15,000 g for 15
min. The supernatants were stored frozen at -20°C over-
night. For analysis, the supernatants were heated at 100°C
Table 1: List of frozen and fixed IBNC tissues available for 
testing
Animal Id Fixed tissue Frozen tissue
2786/93 whole brain Not available
3431/93 whole brain Not available
3990/94 whole brain Not available
3987/94 whole brain Not available
3335/94 whole brain Not available
3382/94 whole brain Not available
0486/96 whole brain Not available
2691/02 obex only medulla only
1165/03 obex only whole brain
2522/03 obex only whole brain
2711/03 obex only whole brain
2850/03 obex only whole brain
2994/03 obex only medulla only
5208/04 half brain half brain
5193/04 obex only whole brain
0522/05 whole brain medulla only
Table 2: Antibodies and dilutions used for 
immunohistochemistry and for biochemistry and their eliciting 
or mapped sequences.
Antibody sequence reference IHC biochemistry
12B2 101WGQGG105# [19] 1:32000 NA
P4¥ 101WGQGGSH107# [20] NA 0.4 μg/ml
12F10 153GSD....PNQ-171* [21] 1:20000 NA
L42 152FGND......VYY174 * [22] 1:1000 NA
6H4 155DYEDRYYRE163# [23] 1:800 NA
SHA31 156YEDRYYRE163# [24] NA 1:10
SAF84 171QVYYRPVDQY181* [25] 1:2000 0.8 μg/ml
F99 228QYQRES233# [26] 1:6000 2 μg/ml
R145 231RESQA235# [19] 1:2000 NA
Codon numbers are according to the bovine PrP sequence where * 
indicates the eliciting sequence or # the mapped sequence.
¥ Antibody raised to sheep sequence which differs at one codon from 
the bovine. NA: not applied.BMC Veterinary Research 2008, 4:38 http://www.biomedcentral.com/1746-6148/4/38
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for 5 minutes, loaded on a 12% Criterion XT Bis-tris SDS
gel (Bio Rad) and subjected to electrophoresis in NuPAGE
running buffer (Invitrogen-California USA) at 200 V for
35 minutes. Proteins were transferred to a PVDF mem-
brane (Bio-Rad) at 115 V for 60 min using NuPAGE trans-
fer buffer.
Blots to be exposed to the SHA31 antibody were blocked
for one hour with the solution provided by the manufac-
turers. Where antibodies F99, SAF84 and P4 were used, a
blocking buffer of 5% milk powder in PBS supplemented
with Tween 20 (PBST) was used. The membranes were
incubated for one hour with the primary antibody: either
SHA31 (Bio-Rad) 1/10 dilution in PBST, SAF84 (Spi Bio,
Paris France) 0.8 μg/ml, P4 (R-BioPharm, Darmstadt, Ger-
many) 0.4 μg/ml, or F99 2 μg/ml (VMRD, Inc. Pullman,
Washington state, USA). The membranes were incubated
with goat anti-mouse IgG antibody (Bio-Rad) conjugated
to horseradish peroxidase diluted 1/10 in PBST. The
membranes were visualized by chemiluminescence (ECL;
Amersham, UK).
For the 4 μl/ml proteinase K concentration the addition of
DNAase and pefabloc was omitted.
ELISA for determination of PrPres
20% homogenates were prepared as for the Western blot
using the Bio-Rad protocol with the modifications
described. The pellets obtained were solubilised by incu-
bating at 100°C for 5 minutes in Reagent C. The method
for the ELISA was carried out as described by the manufac-
turers. The absorbance was measured at 450 nm and 620
nm.
EIA for determination of aggregated PrP using a ligand based 
diagnostic test
For the determination of aggregated PrP in the absence of
proteinase K the Idexx (Maine, USA) HerdChek BSE test
was performed on samples according to the manufac-
turer's instructions with no modifications or deviations.
Briefly samples were mixed with the working plate dilu-
ents and then loaded on a BSE antigen-capture EIA plate
and incubated for 2.5 hours at room temperature. Aggre-
gated PrP was observed using the conjugated anti-PrP
antibodies provided with the kit. Absorbance was read at
450 nm and 620 nm.
Determination of positive values
The cut-off values for the Bio-Rad TeSeE ELISA and Idexx
assays were calculated using the mean of the absorbance
values of 90 confirmed BSE negative brainstem samples+
3 standard deviations. This value was calculated as 0.166
Absorbance units (AU) for the TeSeE ELISA and 0.137 AU
for the Idexx assay. Mean absorbance value and standard
deviation using 0.3 μ/ml proteinase K for the Bio-Rad
assay was 0.066 ± 0.033 (n = 90; range 0.022–0.198) and
for the HerdChek assay 0.056 ± 0.027 (n = 90).
Results
The histology of each IBNC case was reviewed and the
lesions seen were as previously described (Figure 1).
Severe brainstem neuronal chromatolysis (Figure 1a),
often accompanied by nuclear degeneration and occa-
sional amphophilic, intranuclear inclusions, was present
in several brainstem nuclei, being consistently present in
the red nucleus, vestibular complex, dorsal motor nucleus
of the vagal nerve and raphe. In addition, there was severe
axonal and myelin degeneration, prominently affecting
the radices and roots of cranial nerves (Figure 1b). The
degenerative changes of neurons were accompanied by
marked gliosis of parallel severity, and proceeding to
gemistocytosis and non-suppurative inflammation of
meninges and perivascular spaces. Marked spongiform
change with neuronal degeneration was present in the
midbrain, thalamus, striatum and cortex. Not fully
described in previous papers are the different patterns of
vacuolation found in IBNC. Three patterns of vacuolation
were recognized: firstly a large loculated (foamy) vacuole
typically found in the Betz cell layer of the cerebral cortex
(Figure 1c) and also in the thalamus. Single or multiple,
round or ovoid, grey matter vacuoles of a form and char-
acter similar to that of scrapie or BSE were present in the
midbrain, thalamus and striatum. These lesions were not
present in medulla and were specifically absent from BSE
target sites. Thalamic vacuoles were sometimes focally
very numerous and sometimes associated with neuronal
degeneration. These two forms of vacuolation were
present in 6 of 9 cases where whole brain was available for
examination. A third vacuolar change, in which the
neuropil was pale and showed a diffuse lacy appearance
or very small vacuoles was also found (Figure 1d). Sub-
total loss of CA1 and CA2 pyramidal neurons and neu-
rons of the dentate gyrus, was present in 3 of the 9 brains
where hippocampus samples were available for examina-
tion (Figure 1e, f). No significant morphological lesions
were recognised in eye or viscera.
The effective operating dilution for each of the antibodies
was determined for BSE affected sheep or cattle brains and
is listed in Table 2. The efficiency of each antibody for
detection of disease specific PrP found in cattle BSE dif-
fered with F99, 6C2, SAF84 and 12F10 all producing high
intensity labelling. PrP labelling of sections from IBNC
cases was obtained with all antibodies but the ranking of
sensitivity of detection of PrP in IBNC cases and disease
specific PrP in cattle BSE cases was not the same. In partic-
ular 6C2, which give strong labelling of disease specific
PrP accumulations in BSE affected cattle, gave weak label-
ling in IBNC cases. F99 and SAF84 labeled some 'dark'
neurons in control brains tissues and F99 produces someBMC Veterinary Research 2008, 4:38 http://www.biomedcentral.com/1746-6148/4/38
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Histopathology of IBNC Figure 1
Histopathology of IBNC. 1a Case 522/05. Chromatolytic and degenerative changes of neurons of the DMNV HE mag ×225. 
1b. Case 3382/94. Silver staining (black) showing extensive degeneration of myelinated axons in descending fibres of the radix 
of the facial nerve. Glees and Marsland mag ×250. 1c Case 3335/94. Loculated and foamy vacuolation of neuropil adjacent to 
and impinging on pyramidal neurons of the occipital cortex. HE mag ×250. 1d Case 522/05 Fine, lacy, vacuolation of neuropil in 
striatum. HE mag ×500. 1e Case 3382/94 Loss of neurons and reactive gliosis in the pyramidal neurons of the CA1 sector of 
the hippocampus HE mag ×210. 1f Case 3382/94 Gemistocytic replacement gliosis in the CA4 sector (dentate gyrus) of the 
hippocampus. HE mag ×240BMC Veterinary Research 2008, 4:38 http://www.biomedcentral.com/1746-6148/4/38
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weak, diffuse neuropil labelling. All other antibodies were
'clean' with no background staining. IBNC cases showed a
distinctive pattern of PrP labelling that was present in sec-
tions of all IBNC cases but was absent from brains of all
infectious or inflammatory conditions, brains with no sig-
nificant lesions and brains from BSE cases. The same
staining patterns were found in material which had been
preserved in wax or in fixative for widely differing time
intervals; it was reproduced in replicate staining runs and
identical patterns were found with different antibodies.
Thus, we consider that this labelling represents an abnor-
mal form of PrP labelling. However, immunohistochemi-
cal methods alone do not reveal whether such
accumulations are due to increased expression or altered
distribution of normal forms of the protein, or whether
they are PrP accumulations that are abnormal in confor-
mation or aggregation, as they are in BSE and other prion
diseases.
PrP labelling was detected in all IBNC cases though not in
every case at all sites examined (Table 3). F99, SAF84 and
L42 antibodies gave the greatest amounts of labelling. In
most cases labelling was widespread throughout the
brain. In three cases labelling was more or less confined to
the striatum and in one of these three, the labelling was
restricted to the putamen. HE stained sections of these
three cases did not show any large loculated neuropil vac-
uoles. All other cases gave a wide distribution of labelling
including medulla, cerebellum, midbrain, thalamus, stria-
tum, hippocampus and cerebrum. In brainstem sections,
labelling was present in the spinal tract nucleus of the
trigeminal nerve and in the cerebellum, most labelling
involved the cerebellar molecular layer.
Most PrP labelling was found in grey matter (Figure 2b) in
the form of globular, ring or in 'C' shaped patterns (Figure
2c). Occasionally, several of these were arranged in a line.
Very often this pattern of labelling was present at the rim
of small vacuoles (Figure 2c). Some bundles of white mat-
ter in which there was strong vacuolation at the grey mat-
ter interface were also strongly PrP labelled at this
interface with the above pattern. The intensity of PrP
labelling was greatest in those cases in which lesions of
degeneration and spongiform change were most marked.
When the sites of labelling were compared with HE
stained sections this pattern of labelling corresponded to
the 'lacy' neuropil type of micro-vacuolation, both in spe-
cific location within individual sections and in overall
brain distribution. The larger loculated or foamy forms of
vacuoles and more typical scrapie like vacuoles were not
specifically labelled.
In the cerebellum of two cases diffuse labelling was found
in the granular layer and neuropil between granule cell
neuronal nuclei (Figure 2d). Diffuse labelling of both
inner and outer plexiform layers was found in the one eye
(Figure 2e) examined but no labelling was found in the
limited range of viscera. Rarely, degenerate chromatolytic
neurons showed intracytoplasmic labelling (Figure 2a).
Biochemistry
From 2002 all cattle taken under the BSE Regulations were
routinely tested by the BioRad ELISA. The records of 7
IBNC cases from within this period were located. All
results were recorded as negative. Repeat testing of sam-
ples using standard commercial BioRad and Idexx test kits
also gave negative results.
Table 3: showing animals tested, age, tissues available for biochemical testing and the presence and absence of PrP by 
immunohistochemistry.
Animal Id Age immunohistochemistry Routine Immunoblot
medulla whole brain BioRad medulla whole brain
2786/93 7 pos pos NA NA NA
3431/93 8 negative pos NA NA NA
3990/94 5 pos pos NA NA NA
3987/94 10 negative pos NA NA NA
3335/94 8 pos pos NA NA NA
3382/94 10 pos pos NA NA NA
0486/96 NA pos pos NA NA NA
2691/02 15 negative NA Neg yes NA
1165/03 12 pos NA Neg yes yes
2522/03 13 pos NA Neg yes yes
2711/03 10 pos NA Neg yes yes
2850/03 8 pos NA Neg yes yes
2994/03 12 pos NA Neg yes NA
5208/04 12 negative pos Neg yes yes
5193/04 13 pos NA Neg yes yes
0522/05 13 pos pos Neg NA NA
NA tissue or data not availableBMC Veterinary Research 2008, 4:38 http://www.biomedcentral.com/1746-6148/4/38
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PrP immunohistochemistry in IBNC Figure 2
PrP immunohistochemistry in IBNC. 2a Case 1165/03 A degenerate neuron in the DMNV shows intracytoplasmic label-
ling for PrP. F99 antibody mag ×550. 2b Case 522/05. PrP labelling is present in grey matter of the striatum. The white matter 
is unlabelled. F99 antibody mag ×40. 2c Case 3431/93 Detail of grey matter labelling of the caudate nucleus showing the associ-
ation of labelling with the rims of vacuoles and of the neuropil adjacent to small vacuoles. F99 antibody mag ×480. 2d Case 
2786/93 Diffuse labelling of the glomerular zones of neuropil in the cerebellar granule cell layer. F99 antibody mag ×200. 2e 
Case 486/96 Retina showing PrP labelling of the inner and outer plexiform layers of the sensory retina. F99 antibody mag ×120.BMC Veterinary Research 2008, 4:38 http://www.biomedcentral.com/1746-6148/4/38
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The results of BioRad tests using reduced levels of protei-
nase K are shown in table 4. Of the total of 24 IBNC sam-
ples of different brain sites tested, 15 (62.5%) gave values
above those of the test kit negative control and also above
the BSE negative brain pool control. Seven of these sam-
ples (29%) were above the calculated cut off value. Values
above and up to 2 times greater than the calculated cut off
were found for each case but not for each brain site. Indi-
vidual samples from two brains (2691/02 and 1165/03)
which did not initially show results above the calculated
cut off values did so on re-testing (data not shown).
Western blots were carried out on the samples shown in
table 3. In each case no residual protease resistant PrP
(PrPres) was found when 20 or 4 μl/ml of proteinase K was
used. When 0.12 μl/ml or 0.3 μl/ml of proteinase K was
used, a signal was detected on the blots of all samples
including those of the negative controls. IBNC samples
were indistinguishable from negative controls with diges-
tions of 0.12 μl/ml proteinase K. However, when 0.3 μl/
ml of proteinase K was used more residual PrP was
detected in IBNC cases than in the controls (Figure 3) and
with each of the antibodies tested (only illustrations of
F99 are shown).
Discussion
This study shows that the novel condition of cattle previ-
ously identified as IBNC and recognized from within the
BSE suspect submissions, abnormally expresses or accu-
mulates PrP in brain and retina. However, this abnormal
PrP is not composed of isoforms that are strongly resistant
to protease digestion suggesting that it is not present in
the form of large aggregates.
Immunohistochemical demonstration of PrP labelling
and increased levels of PrP mRNA have previously been
described in adult humans affected with acute vascular
disorders, in infants with perinatal hypoxia and experi-
mental infarction of rodents [9]. These findings are con-
sidered to represent upregulation of PrP expression which
encompasses part of the oxidative stress response of neu-
rons. We have also observed increased PrP in the cyto-
plasm of neurons undergoing ischaemic degeneration in
a variety of sheep encephalopathies. Though ischaemic
neuronal degeneration is not a feature of IBNC, neverthe-
less, the presence of PrP within the cytoplasm of some
chromatolytic and degenerate neurons of IBNC affected
cattle is consistent with the idea that stressed neurons may
respond by increasing PrP expression.
Though present in only two cows, the pattern of PrP accu-
mulation within the granule cell layer of the cerebellum is
morphologically similar to that reported by several
authors for Nor 98 types of the transmissible spongiform
encephalopathy or prion disease of sheep [3,10]. The PrP
accumulation within the plexiform layers of the eye is
similar to that of both natural scrapie [11] and of Nor 98
(MJ personal observations). However the majority type of
PrP labelling that occurred in all IBNC cases was found
within the neuropil, mainly in the rostral neuraxis and
cerebrum, the nature of which is previously unreported in
cattle or in any other prion disorder. This novel pattern of
labelling appears to correspond to a rarefaction or fine
microvacuolation of neuropil as seen on standard HE
stained sections.
Pathological, biochemical and bioassay data all suggest
that the epidemic form of cattle BSE is a single strain.
However, recent large scale EU wide surveillance for BSE
has led to the unexpected discovery of rare and hitherto
unknown prion diseases of cattle. Small numbers of atyp-
ical forms of cattle prion diseases have now been recog-
nized from several European countries, in the USA and
Japan and can be distinguished by histological, molecular
and transmission characteristics [12-14]. Bovine Amyloi-
dotic Spongiform Encephalopathy (BASE) was the first of
these novel cattle prion disorders to be recognized and
was characterized by the presence of numerous small
amyloid deposits of abnormal PrP. It was initially discov-
ered in three aged Italian cattle [1] and has subsequently
Table 4: BioRad Elisa tissues results under conditions of mild 
protease digestion
Sample ID tissue site 0.3 [PK] ELISA
2691/02 brain stem 0.088
1165/03 cortex 0.122
1165/03 cerebellum 0.055
1165/03 midbrain 0.078
1165/03 brain stem 0.151
2522/03 cortex 0.083
2522/03 cerebellum 0.285
2522/03 midbrain 0.334
2711/03 cortex 0.210
2711/03 cerebellum 0.241
2711/03 midbrain 0.153
2711/03 brain stem 0.101
2850/03 cortex 0.136
2850/03 cerebellum 0.032
2850/03 midbrain 0.266
2850/03 brain stem 0.146
5193/04 cortex 0.101
5193/04 cerebellum 0.041
5193/04 midbrain 0.229
5193/04 brain stem 0.063
5208/04 cortex 0.094
5208/04 cerebellum 0.049
5208/04 midbrain 0.122
5208/04 brain stem 0.194
-ve BSE brain pool control 0.100
-ve kit control 0.011
Calculated cut off value 0.165
Values in bold are above the calculated cut off.BMC Veterinary Research 2008, 4:38 http://www.biomedcentral.com/1746-6148/4/38
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been transmitted to transgenic mice [13,14]. A further var-
iant of a cattle prion disease affecting cows between 8 and
15 years was initially recognized in France [2] and has also
been transmitted to mice. BSE and these novel cattle prion
diseases can be distinguished using biochemical and
molecular methods and are now classified as C, H and L
type isolates [12]. H type and L type (BASE) isolates are
defined according to the higher and lower positions of the
unglycosylated PrPres bands in Western blots, respectively,
when compared to the position of the corresponding
band in classical BSE (C type) isolates [12]. L type cases
formerly classified as BASE, have a distinctive glycopattern
in which monoglycoslyated PrPres  predominates com-
pared to BSE [12,14]. While IBNC cases are on average
older than BSE cases they occupy a similar age class of cat-
tle to that of H and L type cattle prion diseases, but IBNC
can be readily distinguished from H, L and C type cattle
prion disease by morphologic pathology and by the
absence of PrPres under stringent conditions of protease
digestion.
Not all abnormal PrPres isoforms detected from brains of
animals affected with prion disease are resistant to strin-
gent protease digestion. The PrPres of two sheep of the
ARR/ARR PrP genotype affected with a classical scrapie-
like disease accumulated unusually protease sensitive iso-
forms of PrP [15]. Similarly, the transmissible prion dis-
ease of sheep known as Nor 98 and related conditions
(often referred to as atypical scrapie) also have weakly
protease resistant PrPres [3,16]. Nor 98 does not appear to
PrP immunoblots on IBNC and BSE cases Figure 3
PrP immunoblots on IBNC and BSE cases. Western blot of 5 different IBNC midbrain samples digested with 4 μl (lanes 
2,4,6,11, 13) or 0.3 μl/ml (lanes 3,5,7,12,14) of proteinase K. An individual control brain digested with 4 μ (lane 9,) or 0.3 μl/ml 
(lane10) proteinase K and a control brain (lane 16) and pooled BSE brains (lanes 17) digested with 20 μl/ml of proteinase K are 
also present. Molecular markers are at lanes 1,8, and 15. In each case 4 μl/ml proteinase K results in complete digestion of PrP. 
Although residual PrPc is present in control brain each of the IBNC brains gives a stronger signal and multiple labelled bands 
when developed with the F99 antibody at 15 minutes exposure.
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transmit readily to other sheep under field conditions: it
also does not transmit to conventional mice although it
does readily transmit disease to one strain of transgenic
mouse which substantially over-expresses the VRQ allele
of sheep PrP [16,17]. The transgenic PG14 mouse also has
PrPres which is even more readily digested than that found
in Nor 98 but this prion protein disorder has not so far
been successfully transmitted [18]. The biochemical anal-
yses of limited numbers of IBNC cases clearly shows that
highly aggregated forms of protease resistant PrP are not
present in brain tissue. However, when the data from the
ELISA and immunoblot tests using mild protease diges-
tion are compared with that of normal control material it
is possible that smaller aggregates of PrP molecules may
be present.
Conclusion
The present results indicate that there are changes in PrP
expression or accumulation in the neurodegenerative cat-
tle disorder known as IBNC. The pathology and biochem-
istry of IBNC are quite distinct from that of other prion
diseases of cattle and other species but the pathology does
include grey matter spongiform changes. The transmissi-
bility of this disorder is undetermined. These results are
interesting as they show that either the range of prion dis-
eases and associated pathology is still wider than previ-
ously thought or that substantial abnormalities of prion
protein expression may be associated with brain lesions
unconnected with classical prion diseases. Further bio-
chemical and transmission studies are needed to deter-
mine which of these possibilities is correct.
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